Severe COVID-19-related encephalitis can respond to immunotherapy
Severe COVID-19-related encephalitis can respond to immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Severe COVID-19-related encephalitis can respond to immunotherapy have?
Severe COVID-19-related encephalitis can respond to immunotherapy has 66 citations in the OpenAlex counts ScholarIQ stores.
When was Severe COVID-19-related encephalitis can respond to immunotherapy published?
Severe COVID-19-related encephalitis can respond to immunotherapy has 2020 year in the ScholarIQ index.
What is the open-access status of Severe COVID-19-related encephalitis can respond to immunotherapy?
Severe COVID-19-related encephalitis can respond to immunotherapy has bronze oa status in the ScholarIQ index.
What is the DOI of Severe COVID-19-related encephalitis can respond to immunotherapy?
The DOI for Severe COVID-19-related encephalitis can respond to immunotherapy is on the source record.
What is the PMID of Severe COVID-19-related encephalitis can respond to immunotherapy?
The PMID for Severe COVID-19-related encephalitis can respond to immunotherapy is on the source record.
What is the OpenAlex record for Severe COVID-19-related encephalitis can respond to immunotherapy?
The OpenAlex for Severe COVID-19-related encephalitis can respond to immunotherapy is on the source record.